# OnCo record paper-galdy-her2-biliary-tract-meta-analysis-cancer-metastasis-rev-2017 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-galdy-her2-biliary-tract-meta-analysis-cancer-metastasis-rev-2017/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-galdy-her2-biliary-tract-meta-analysis-cancer-metastasis-rev-2017" ;
  schema:name "HER2/HER3 pathway in biliary tract malignancies; systematic review and meta-analysis: a potential therapeutic target?"@en ;
  schema:description "Pooling 40 studies, about one in five bile duct and gallbladder cancers outside the liver over-express HER2, against fewer than one in twenty inside the liver, which is why HER2 drugs matter most for gallbladder cancer."@en ;
  schema:url <https://onco.cc/key-papers/paper-galdy-her2-biliary-tract-meta-analysis-cancer-metastasis-rev-2017/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://doi.org/10.1007/s10555-016-9645-x>, <https://pubmed.ncbi.nlm.nih.gov/27981460/> ;
  onco:tag "gallbladder-evidence" ;
  schema:sameAs <https://doi.org/10.1007/s10555-016-9645-x> ;
  schema:datePublished "2017"^^xsd:gYear ;
  schema:author "Galdy S, Lamarca A, McNamara MG, et al." ;
  onco:cancers <https://onco.cc/cancers/gallbladder/>, <https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/>, <https://onco.cc/cancers/biliary-tract-cancer/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:terms <https://onco.cc/terms/her2-positive/>, <https://onco.cc/terms/ihc/>, <https://onco.cc/terms/fish/> ;
  onco:people <https://onco.cc/people/angela-lamarca/>, <https://onco.cc/people/juan-valle/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-biomarker-validation/> ;
  onco:journals <https://onco.cc/journals/cancer-metastasis-reviews/> .